Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All?
Guideline-based management of acute coronary syndrome (ACS) is well established, yet some may challenge that strict implementation of guideline recommendations can limit the individualization of therapy. The use of all recommended medications following ACS places a high burden of responsibility and...
Gespeichert in:
| Veröffentlicht in: | American journal of cardiovascular drugs : drugs, devices, and other interventions devices, and other interventions, 2016-02, Vol.16 (1), p.9-17 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 17 |
|---|---|
| container_issue | 1 |
| container_start_page | 9 |
| container_title | American journal of cardiovascular drugs : drugs, devices, and other interventions |
| container_volume | 16 |
| creator | Bernal, Daniel D. L. Bereznicki, Luke R. E. Chalmers, Leanne Castelino, Ronald L. Thompson, Angus Davidson, Patricia M. Peterson, Gregory M. |
| description | Guideline-based management of acute coronary syndrome (ACS) is well established, yet some may challenge that strict implementation of guideline recommendations can limit the individualization of therapy. The use of all recommended medications following ACS places a high burden of responsibility and cost on patients, particularly when these medications have not been previously prescribed. Without close attention to avoiding non-adherence to these medications, the full benefits of the guideline recommendations will not be realized in many patients. Using a case example, we discuss how the recognition of adherence barriers can be an effective and efficient process for identifying patients at risk of non-adherence following ACS. For those identified as at risk, the World Health Organization’s model of adherence barriers is explored as a potentially useful tool to assist with individualization of therapy and promotion of adherence. |
| doi_str_mv | 10.1007/s40256-015-0149-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1781341722</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4024529161</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-f0863adc94ec0f6f7527eb9ba95290758ae2ef38118dd0fb149fe7822e9e821d3</originalsourceid><addsrcrecordid>eNp1kF9LwzAUxYMobk4_gC8S8LmapH-S-CJlOhWme5iCb6FtbmdH18ykReanN7NTfPHhkgs551zOD6FTSi4oIfzSRYTFSUBo7CeSgdxDQ0q5DKjgr_vfexyEjPMBOnJuSQjljMtDNGBJHHGRJEP09Ai6KrK2Mg1O9RtYaArAE1PX5qNqFjgtuhbw2FjTZHaD55tGW7OCK3xjwOFZA3hefXpD1eK0rq-P0UGZ1Q5Odu8IvUxun8f3wXR29zBOp0ERRawNSiKSMNOFjKAgZVLymHHIZZ7JmEnCY5EBgzIUlAqtSZn7ciVwwRhIEIzqcITO-9y1Ne8duFYtTWcbf1JRLmgY-abMq2ivKqxxzkKp1rZa-R6KErUlqHqCyhNUW4JKes_ZLrnLV6B_HT_IvID1Aue_mgXYP6f_Tf0C-nt6Zg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781341722</pqid></control><display><type>article</type><title>Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All?</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Bernal, Daniel D. L. ; Bereznicki, Luke R. E. ; Chalmers, Leanne ; Castelino, Ronald L. ; Thompson, Angus ; Davidson, Patricia M. ; Peterson, Gregory M.</creator><creatorcontrib>Bernal, Daniel D. L. ; Bereznicki, Luke R. E. ; Chalmers, Leanne ; Castelino, Ronald L. ; Thompson, Angus ; Davidson, Patricia M. ; Peterson, Gregory M.</creatorcontrib><description>Guideline-based management of acute coronary syndrome (ACS) is well established, yet some may challenge that strict implementation of guideline recommendations can limit the individualization of therapy. The use of all recommended medications following ACS places a high burden of responsibility and cost on patients, particularly when these medications have not been previously prescribed. Without close attention to avoiding non-adherence to these medications, the full benefits of the guideline recommendations will not be realized in many patients. Using a case example, we discuss how the recognition of adherence barriers can be an effective and efficient process for identifying patients at risk of non-adherence following ACS. For those identified as at risk, the World Health Organization’s model of adherence barriers is explored as a potentially useful tool to assist with individualization of therapy and promotion of adherence.</description><identifier>ISSN: 1175-3277</identifier><identifier>EISSN: 1179-187X</identifier><identifier>DOI: 10.1007/s40256-015-0149-9</identifier><identifier>PMID: 26547866</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Acute Coronary Syndrome - drug therapy ; Cardiology ; Current Opinion ; Humans ; Medication Adherence ; Medicine ; Medicine & Public Health ; Pharmacology/Toxicology ; Pharmacotherapy ; Practice Guidelines as Topic ; Precision Medicine ; Risk</subject><ispartof>American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016-02, Vol.16 (1), p.9-17</ispartof><rights>Springer International Publishing Switzerland 2015</rights><rights>Copyright Springer Science & Business Media Feb 2016</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-f0863adc94ec0f6f7527eb9ba95290758ae2ef38118dd0fb149fe7822e9e821d3</citedby><cites>FETCH-LOGICAL-c442t-f0863adc94ec0f6f7527eb9ba95290758ae2ef38118dd0fb149fe7822e9e821d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40256-015-0149-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40256-015-0149-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26547866$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bernal, Daniel D. L.</creatorcontrib><creatorcontrib>Bereznicki, Luke R. E.</creatorcontrib><creatorcontrib>Chalmers, Leanne</creatorcontrib><creatorcontrib>Castelino, Ronald L.</creatorcontrib><creatorcontrib>Thompson, Angus</creatorcontrib><creatorcontrib>Davidson, Patricia M.</creatorcontrib><creatorcontrib>Peterson, Gregory M.</creatorcontrib><title>Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All?</title><title>American journal of cardiovascular drugs : drugs, devices, and other interventions</title><addtitle>Am J Cardiovasc Drugs</addtitle><addtitle>Am J Cardiovasc Drugs</addtitle><description>Guideline-based management of acute coronary syndrome (ACS) is well established, yet some may challenge that strict implementation of guideline recommendations can limit the individualization of therapy. The use of all recommended medications following ACS places a high burden of responsibility and cost on patients, particularly when these medications have not been previously prescribed. Without close attention to avoiding non-adherence to these medications, the full benefits of the guideline recommendations will not be realized in many patients. Using a case example, we discuss how the recognition of adherence barriers can be an effective and efficient process for identifying patients at risk of non-adherence following ACS. For those identified as at risk, the World Health Organization’s model of adherence barriers is explored as a potentially useful tool to assist with individualization of therapy and promotion of adherence.</description><subject>Acute Coronary Syndrome - drug therapy</subject><subject>Cardiology</subject><subject>Current Opinion</subject><subject>Humans</subject><subject>Medication Adherence</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacotherapy</subject><subject>Practice Guidelines as Topic</subject><subject>Precision Medicine</subject><subject>Risk</subject><issn>1175-3277</issn><issn>1179-187X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kF9LwzAUxYMobk4_gC8S8LmapH-S-CJlOhWme5iCb6FtbmdH18ykReanN7NTfPHhkgs551zOD6FTSi4oIfzSRYTFSUBo7CeSgdxDQ0q5DKjgr_vfexyEjPMBOnJuSQjljMtDNGBJHHGRJEP09Ai6KrK2Mg1O9RtYaArAE1PX5qNqFjgtuhbw2FjTZHaD55tGW7OCK3xjwOFZA3hefXpD1eK0rq-P0UGZ1Q5Odu8IvUxun8f3wXR29zBOp0ERRawNSiKSMNOFjKAgZVLymHHIZZ7JmEnCY5EBgzIUlAqtSZn7ciVwwRhIEIzqcITO-9y1Ne8duFYtTWcbf1JRLmgY-abMq2ivKqxxzkKp1rZa-R6KErUlqHqCyhNUW4JKes_ZLrnLV6B_HT_IvID1Aue_mgXYP6f_Tf0C-nt6Zg</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Bernal, Daniel D. L.</creator><creator>Bereznicki, Luke R. E.</creator><creator>Chalmers, Leanne</creator><creator>Castelino, Ronald L.</creator><creator>Thompson, Angus</creator><creator>Davidson, Patricia M.</creator><creator>Peterson, Gregory M.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20160201</creationdate><title>Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All?</title><author>Bernal, Daniel D. L. ; Bereznicki, Luke R. E. ; Chalmers, Leanne ; Castelino, Ronald L. ; Thompson, Angus ; Davidson, Patricia M. ; Peterson, Gregory M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-f0863adc94ec0f6f7527eb9ba95290758ae2ef38118dd0fb149fe7822e9e821d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acute Coronary Syndrome - drug therapy</topic><topic>Cardiology</topic><topic>Current Opinion</topic><topic>Humans</topic><topic>Medication Adherence</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacotherapy</topic><topic>Practice Guidelines as Topic</topic><topic>Precision Medicine</topic><topic>Risk</topic><toplevel>online_resources</toplevel><creatorcontrib>Bernal, Daniel D. L.</creatorcontrib><creatorcontrib>Bereznicki, Luke R. E.</creatorcontrib><creatorcontrib>Chalmers, Leanne</creatorcontrib><creatorcontrib>Castelino, Ronald L.</creatorcontrib><creatorcontrib>Thompson, Angus</creatorcontrib><creatorcontrib>Davidson, Patricia M.</creatorcontrib><creatorcontrib>Peterson, Gregory M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>American journal of cardiovascular drugs : drugs, devices, and other interventions</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bernal, Daniel D. L.</au><au>Bereznicki, Luke R. E.</au><au>Chalmers, Leanne</au><au>Castelino, Ronald L.</au><au>Thompson, Angus</au><au>Davidson, Patricia M.</au><au>Peterson, Gregory M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All?</atitle><jtitle>American journal of cardiovascular drugs : drugs, devices, and other interventions</jtitle><stitle>Am J Cardiovasc Drugs</stitle><addtitle>Am J Cardiovasc Drugs</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>16</volume><issue>1</issue><spage>9</spage><epage>17</epage><pages>9-17</pages><issn>1175-3277</issn><eissn>1179-187X</eissn><abstract>Guideline-based management of acute coronary syndrome (ACS) is well established, yet some may challenge that strict implementation of guideline recommendations can limit the individualization of therapy. The use of all recommended medications following ACS places a high burden of responsibility and cost on patients, particularly when these medications have not been previously prescribed. Without close attention to avoiding non-adherence to these medications, the full benefits of the guideline recommendations will not be realized in many patients. Using a case example, we discuss how the recognition of adherence barriers can be an effective and efficient process for identifying patients at risk of non-adherence following ACS. For those identified as at risk, the World Health Organization’s model of adherence barriers is explored as a potentially useful tool to assist with individualization of therapy and promotion of adherence.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>26547866</pmid><doi>10.1007/s40256-015-0149-9</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1175-3277 |
| ispartof | American journal of cardiovascular drugs : drugs, devices, and other interventions, 2016-02, Vol.16 (1), p.9-17 |
| issn | 1175-3277 1179-187X |
| language | eng |
| recordid | cdi_proquest_journals_1781341722 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Acute Coronary Syndrome - drug therapy Cardiology Current Opinion Humans Medication Adherence Medicine Medicine & Public Health Pharmacology/Toxicology Pharmacotherapy Practice Guidelines as Topic Precision Medicine Risk |
| title | Medication Adherence Following Acute Coronary Syndrome: Does One Size Fit All? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T20%3A13%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medication%20Adherence%20Following%20Acute%20Coronary%20Syndrome:%20Does%20One%20Size%20Fit%20All?&rft.jtitle=American%20journal%20of%20cardiovascular%20drugs%20:%20drugs,%20devices,%20and%20other%20interventions&rft.au=Bernal,%20Daniel%20D.%20L.&rft.date=2016-02-01&rft.volume=16&rft.issue=1&rft.spage=9&rft.epage=17&rft.pages=9-17&rft.issn=1175-3277&rft.eissn=1179-187X&rft_id=info:doi/10.1007/s40256-015-0149-9&rft_dat=%3Cproquest_cross%3E4024529161%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781341722&rft_id=info:pmid/26547866&rfr_iscdi=true |